According to a recent article posted in the Pain News Network, clinical trials involving the study of cannabis and CBD in a variety of interventional settings are expected to take off now that regulations around such investigations seem to be loosening up for the Canadian and U.S.-based research communities thanks to new regulations both in the United States and in Canada.
A new clinical trial taking place in Canada seeks to examine cannabis vs. fentanyl for the management of pain, in particular for cancer patients.
From the article:
This is a Phase II trial with two goals. First, an open-label randomized study to evaluate the effects of cannabis versus fentanyl in adults with breakthrough cancer pain who are already on opioids. Second, a randomized double-blind placebo-controlled trial to evaluate the effect of cannabis or fentanyl as compared to a placebo group with breakthrough cancer pain.